Get started
Author

Jinsheng Liang

OpenAlex ID: A5114045823
Supplementary Data from Inhibition of MDM2 Promotes Antitumor Responses in p53 Wild-Type Cancer Cells through Their Interaction with the Immune and Stromal Microenvironment
2023 · Hui Qin Wang, Iain J. Mulford, et al.
Figure S2 from LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
2023 · Kelli-Ann Monaco, Scott Delach, et al.
Table S3 from LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
2023 · Kelli-Ann Monaco, Scott Delach, et al.
Table S5 from LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
2023 · Kelli-Ann Monaco, Scott Delach, et al.
Supplementary Legend from LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
2023 · Kelli-Ann Monaco, Scott Delach, et al.
Table S1 from LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
2023 · Kelli-Ann Monaco, Scott Delach, et al.
Table S9 from LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
2023 · Kelli-Ann Monaco, Scott Delach, et al.
Table S6 from LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
2023 · Kelli-Ann Monaco, Scott Delach, et al.
Figure S1 from LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
2023 · Kelli-Ann Monaco, Scott Delach, et al.
Table S7 from LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
2023 · Kelli-Ann Monaco, Scott Delach, et al.
Figure S4 from LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
2023 · Kelli-Ann Monaco, Scott Delach, et al.
Table S8 from LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
2023 · Kelli-Ann Monaco, Scott Delach, et al.
Table S4 from LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
2023 · Kelli-Ann Monaco, Scott Delach, et al.
Table S2 from LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
2023 · Kelli-Ann Monaco, Scott Delach, et al.
Figure S3 from LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
2023 · Kelli-Ann Monaco, Scott Delach, et al.
Supplementary Data from Inhibition of MDM2 Promotes Antitumor Responses in p53 Wild-Type Cancer Cells through Their Interaction with the Immune and Stromal Microenvironment
2023 · Hui Qin Wang, Iain J. Mulford, et al.
PDF
Supplementary Legend from LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
2023 · Kelli-Ann Monaco, Scott Delach, et al.
Figure S1 from LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
2023 · Kelli-Ann Monaco, Scott Delach, et al.
Table S2 from LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
2023 · Kelli-Ann Monaco, Scott Delach, et al.
Figure S3 from LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
2023 · Kelli-Ann Monaco, Scott Delach, et al.
Table S1 from LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
2023 · Kelli-Ann Monaco, Scott Delach, et al.
Table S9 from LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
2023 · Kelli-Ann Monaco, Scott Delach, et al.
Table S3 from LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
2023 · Kelli-Ann Monaco, Scott Delach, et al.
Figure S2 from LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
2023 · Kelli-Ann Monaco, Scott Delach, et al.
Figure S4 from LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
2023 · Kelli-Ann Monaco, Scott Delach, et al.
Works count: 32
Citation count:
H-index:
I10-index:
Year
Topic
Type